Lisata shareholders re-elect Azab, Klosk; approve ESPP, auditor, say-on-pay, one-year frequency

LISATA THERAPEUTICS, INC.

Re-elected Mohammad Azab (3,809,977 for) and Steven Klosk (3,788,000 for) as Class III directors to 2028.
Approved amendment to 2017 ESPP increasing shares from 113,333 to 158,333 (3,523,229 for, 294,116 against, 378,495 abstain).
Ratified Grant Thornton LLP as independent auditor for FY2025 (6,226,674 for, 64,171 against, 136,348 abstain).
Non-binding advisory votes: approved executive compensation (3,496,571 for) and selected one-year frequency for future say-on-pay votes (3,967,202 for one year).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.